These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 31295531)

  • 21. Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
    Yang YY; Hsieh SL; Lee PC; Yeh YC; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Chan CC; Lin HC
    J Hepatol; 2014 Nov; 61(5):1004-13. PubMed ID: 24953022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
    Gómez-Hurtado I; Zapater P; Portune K; Juanola O; Fernández-Iglesias A; González-Navajas JM; Gracia-Sancho J; Sanz Y; Francés R
    Eur J Nutr; 2019 Jun; 58(4):1647-1658. PubMed ID: 29748815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
    Verbeke L; Farre R; Trebicka J; Komuta M; Roskams T; Klein S; Elst IV; Windmolders P; Vanuytsel T; Nevens F; Laleman W
    Hepatology; 2014 Jun; 59(6):2286-98. PubMed ID: 24259407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.
    Inagaki T; Moschetta A; Lee YK; Peng L; Zhao G; Downes M; Yu RT; Shelton JM; Richardson JA; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3920-5. PubMed ID: 16473946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl
    Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J
    Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.
    Seo YS; Shah VH
    Clin Mol Hepatol; 2012 Dec; 18(4):337-46. PubMed ID: 23323248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
    Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
    Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension.
    Schwabl P; Seeland BA; Riedl F; Schubert TL; Königshofer P; Brusilovskaya K; Petrenko O; Hofer B; Schiefer AI; Trauner M; Peck-Radosavljevic M; Reiberger T
    Adv Med Sci; 2022 Mar; 67(1):154-162. PubMed ID: 35272246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction.
    Yan M; Hou L; Cai Y; Wang H; Ma Y; Geng Q; Jiang W; Tang W
    Front Pharmacol; 2022; 13():906452. PubMed ID: 35770078
    [No Abstract]   [Full Text] [Related]  

  • 32. Potential mechanisms linking gut microbiota and portal hypertension.
    Baffy G
    Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.
    Geerts AM; Vanheule E; Praet M; Van Vlierberghe H; De Vos M; Colle I
    Int J Exp Pathol; 2008 Aug; 89(4):251-63. PubMed ID: 18715470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension.
    Uschner FE; Ranabhat G; Choi SS; Granzow M; Klein S; Schierwagen R; Raskopf E; Gautsch S; van der Ven PF; Fürst DO; Strassburg CP; Sauerbruch T; Diehl AM; Trebicka J
    Sci Rep; 2015 Sep; 5():14573. PubMed ID: 26412302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.
    Sánchez E; Nieto JC; Boullosa A; Vidal S; Sancho FJ; Rossi G; Sancho-Bru P; Oms R; Mirelis B; Juárez C; Guarner C; Soriano G
    Liver Int; 2015 Mar; 35(3):735-45. PubMed ID: 24750552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation.
    Hao Y; Hao Z; Zeng X; Lin Y
    J Gastroenterol; 2024 Sep; 59(9):788-797. PubMed ID: 39028343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis.
    Mohandas S; Vairappan B
    Chem Biol Interact; 2020 Jan; 315():108891. PubMed ID: 31697926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginkgolide-A attenuates bacterial translocation through activating PXR and improving antimicrobial peptide Reg 3A in experimental cirrhosis.
    Mohandas S; Vairappan B
    Life Sci; 2020 Sep; 257():118111. PubMed ID: 32682918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.